Citius Oncology, Inc. ("Citius Oncology") (Nasdaq: CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals, Inc. ("Citius Pharma") (Nasdaq: CTXR), today announced the commercial launch of ...
While limited data suggest loncastuximab tesirine plus rituximab may be active in the third line, larger cohorts and ...
THERE are few things as satisfying as scratching an itch. But when your itch keeps recurring and starts to affect your day-to ...
Why a growing number of women are reporting unexplained symptoms, inflammation and anxiety linked to implants—prompting a ...
Citius Oncology, Inc. ("Citius Oncology") (Nasdaq: CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals, Inc. ("Citius Pharma") (Nasdaq: CTXR), a late-stage biopharmaceutical company ...
AbbVie just scored a major regulatory win at home base. The company’s cancer drug Epkinly has been cleared by the U.S. Food and Drug Administration to be used with rituximab and lenalidomide in adults ...
GB News on MSN
'I was diagnosed with stage 3 cancer at 22 - the signs emerged gradually across my body'
The UK is seeing an increase in Hodgkin lymphoma cases, and forecasts indicate this upward trend will persist without targeted health measures. Data from Cancer Research UK shows the condition most ...
EPKINLY plus rituximab and lenalidomide (EPKINLY + R 2) is the first and only bispecific-based therapy approved by the FDA for follicular lymphoma in the second-line setting In the Phase 3 EPCORE ® FL ...
Wash the area with soap and water right away if you touch caterpillar hairs. Use over-the-counter medicines like cortisone cream to ease rash symptoms. Contact a healthcare provider if the rash is ...
Trinity School of Medicine researchers, along with UK collaborators, have created a simple but powerful diagnostic tool, which they believe will change a patient’s life in the diagnosis of a type of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback